omeprazole has been researched along with Birth Weight in 2 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Birth Weight: The mass or quantity of heaviness of an individual at BIRTH. It is expressed by units of pounds or kilograms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Our purpose was to determine whether omeprazole use during pregnancy is associated with an increased risk of malformations, spontaneous abortions, decreased birth weight, or perinatal complications." | 9.08 | The safety of omeprazole during pregnancy: a multicenter prospective controlled study. ( Addis, A; Bonati, M; Koren, G; Lalkin, A; Loebstein, R; Mastroiacovo, P; Mazzone, T; Ramezani-Namin, F; Vial, T, 1998) |
| "To evaluate the magnitude of possible fetal risks involved in maternal use of omeprazole during pregnancy." | 7.71 | Use of omeprazole during pregnancy--no hazard demonstrated in 955 infants exposed during pregnancy. ( Källén, BA, 2001) |
| "Our purpose was to determine whether omeprazole use during pregnancy is associated with an increased risk of malformations, spontaneous abortions, decreased birth weight, or perinatal complications." | 5.08 | The safety of omeprazole during pregnancy: a multicenter prospective controlled study. ( Addis, A; Bonati, M; Koren, G; Lalkin, A; Loebstein, R; Mastroiacovo, P; Mazzone, T; Ramezani-Namin, F; Vial, T, 1998) |
| "To evaluate the magnitude of possible fetal risks involved in maternal use of omeprazole during pregnancy." | 3.71 | Use of omeprazole during pregnancy--no hazard demonstrated in 955 infants exposed during pregnancy. ( Källén, BA, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lalkin, A | 1 |
| Loebstein, R | 1 |
| Addis, A | 1 |
| Ramezani-Namin, F | 1 |
| Mastroiacovo, P | 1 |
| Mazzone, T | 1 |
| Vial, T | 1 |
| Bonati, M | 1 |
| Koren, G | 1 |
| Källén, BA | 1 |
1 trial available for omeprazole and Birth Weight
| Article | Year |
|---|---|
The safety of omeprazole during pregnancy: a multicenter prospective controlled study.
Topics: Abnormalities, Drug-Induced; Adult; Birth Weight; Delivery, Obstetric; Enzyme Inhibitors; Female; Ga | 1998 |
1 other study available for omeprazole and Birth Weight
| Article | Year |
|---|---|
Use of omeprazole during pregnancy--no hazard demonstrated in 955 infants exposed during pregnancy.
Topics: Abnormalities, Drug-Induced; Abnormalities, Multiple; Adult; Anti-Ulcer Agents; Apgar Score; Birth W | 2001 |